Oncogenic NRG1 Fusions: A New Hope for Targeted Therapy in Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-19-1280
Abstract: Approximately 8%–10% of pancreatic ductal adenocarcinoma cases are KRAS wild type. In a subset of these tumors, NRG1 gene fusions have been identified as targetable oncogenic drivers, a discovery that highlights the importance of deep… read more here.
Keywords: hope targeted; nrg1 fusions; cancer; fusions new ... See more keywords